Structural studies on New Delhi Metallo-β-lactamase (NDM-2) suggest old β-lactam, penicillin to be better antibiotic for NDM-2-harbouring Acinetobacter baumanni

Journal of Biomolecular Structure and Dynamics

Volumn 31, Issue 6, 2013, Pages 591-601

  Tiwari, Vishvanath ^a   Moganty, Rajeswari R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Acinetobacter baumannii; Carbapenem resistance; NDM; NDM 2; New Delhi Metallo Lactamase; OXA 24; Penicillin

Indexed keywords

AZTREONAM; BETA LACTAMASE; CEFTAZIDIME; DORIPENEM; HYDROLASE; IMIPENEM; NEW DELHI METALLO BETA LACTAMASE 2; NITROCEFIN; OXA 24 PROTEIN; OXACILLIN; PENICILLIN DERIVATIVE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BINDING AFFINITY; COMPLEX FORMATION; COMPUTER MODEL; DRUG PROTEIN BINDING; DRUG STRUCTURE; ENZYME STRUCTURE; MOLECULAR DOCKING; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; BINDING SITES; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR DYNAMICS SIMULATION; PENICILLINS;

ACINETOBACTER BAUMANNII; NEGIBACTERIA;

EID: 84878689439     PISSN: 07391102     EISSN: 15380254     Source Type: Journal    
DOI: 10.1080/07391102.2012.706075     Document Type: Article

References (44)

1. Boucher, H.W., Talbot, G.H., Bradley, J.S., Edwards, J.E., Gilbert, D., Rice, L.B.,., and, Bartlett, J. 2009. Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America. Clinical Infectious Diseases, 48: 1-12.
2. Bryan, C.S. (1A). Treatment of pneumococcal pneumonia: The case for penicillin G. American Journal of Medicine, 107, 63s-68s.
3. Cawley, M.J., Suh, C., Lee, S., and, Ackerman, B.H. 2002. Nontraditional dosing of ampicillin-sulbactam for multidrug-resistant Acinetobacter baumannii meningitis. Pharmacotherapy, 22: 527-532.
4. Chen, Y., Zhou, Z., Jiang, Y., and, Yu, Y. 2011. Emergence of NDM-1-producing Acinetobacter baumannii in China. Journal of Antimicrobial Chemotherapy, 66: 1255-1259.
5. Espinal, P., Fugazza, G., Lopez, Y., Kasma, M., Lerman, Y., Malhotra-Kumar, S., Goossens, H., Carmeli, Y., and, Vila, J. 2011. Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center. Antimicrobial Agents and Chemotherapy, 55 (11): 5396-5398.
6. Fernandez-Cuenca, F., Martinez-Martinez, L., Conejo, M.C., Ayala, J.A., Perea, E.J., and, Pascual, A. 2003. Relationship between β-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy, 51: 565-574.
7. Garau, G., Bebrone, C., Anne, C., Galleni, M., Frere, J.M., and, Dideberg, O. 2005. A metallo-β-lactamase enzyme in action: Crystal structures of the monozinc carbapenemase CphA and its complex with biapenem. Journal of Molecular Biology, 345: 785-795.
8. Ghazawi, A., Sonnevend, A., Bonnin, R.A., Poirel, L., Nordmann, P., Hashmey, R., Rizvi, T.A., Hamadeh, M.B., and, Pal, T. 2012. NDM-2 carbapenemase-producing Acinetobacter baumannii in the United Arab Emirates. Clinical Microbiology & Infection, 18: E34-E36.
9. Giannouli, M., Tomasone, F., Agodi, A., Vahaboglu, H., Daoud, Z., Triassi, M., Tsakris, A., and, Zarrilli, R. 2009. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii strains in intensive care units of multiple Mediterranean hospitals. Journal of Antimicrobial Chemotherapy, 63 (4): 828-830.
10. Gottig, S., Pfeifer, Y., Wichelhaus, T.A., Zacharowski, K., Bingold, T., Averhoff, B.,., and, Kempf, V.A.J. 2010. Global spread of New Delhi metallo-b-lactamase 1. The Lancet Infectious Diseases, 10: 828-829.
11. Hendlich, M., Rippmann, F., and, Barnickel, G. 1997. LIGSITE: Automatic and efficient detection of potential small molecule-binding sites in proteins. Journal of Molecular Graphics and Modelling, 15: 359-363.
12. Jimenez-Mejias, M.E., Becerril, B., Marquez-Rivas, F.J., Pichardo, C., Cuberos, L., and, Pachon, J. 2000. Successful treatment of multidrug-resistant Acinetobacter baumannii meningitis with intravenous colistin sulfomethate sodium. European Journal of Clinical Microbiology and Infectious Diseases, 19: 970-971.
13. Kaase, M., Nordmann, P., Wichelhaus, T.A., Gatermann, S.G., Bonnin, R.A., and, Poirel, L. 2011. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. Journal of Antimicrobial Chemotherapy, 66: 1260-1262.
14. Karthikeyan, K., Thirunarayan, M.A., and, Krishnan, P. 2010. Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. Journal of Antimicrobial Chemotherapy, 65: 2253-2254.
15. Koh, T.H., Khoo, C.T., Wijaya, L., Leong, H.N., Lo, Y.L., Lim, L.C., and, Koh, T.Y. 2010. Global spread of New Delhi metallo-β-lactamase-1. The Lancet Infectious Diseases, 10: 828-829.
16. Kohlenberg, A., Brummer, S., Higgins, P.G., Sohr, D., Piening, B.C., de Grahal, C.,., and, Seifert, H. 2009. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre. Journal of Medical Microbiology, 58: 1499-1507.
17. Kumarasamy, K.K., Toleman, M.A., Walsh, T.R., Bagaria, J., Butt, F., Balakrishnan, R.,., and, Woodford, N. 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: A molecular, biological, and epidemiological study. The Lancet Infectious Diseases, 10: 597-602.
18. Macheboeuf, P., Contreras-Martel, C., Job, V., Dideberg, O., and, Dessen, A. 2006. Penicillin binding proteins: Key players in bacterial cell cycle and drug resistance processes. FEMS Microbial Reviews, 30: 673-691.
19. Manchanda, V., Sanchaita, S., and, Singh, N.P. 2010. Multidrug Resistant Acinetobacter. Journal of Global Infectious Diseases, 2 (3): 291-304.
20. Papa, A., Koulourida, V., and, Souliou, E. 2009. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in a newly established Greek hospital. Microbial Drug Resistance, 15 (4): 257-260.
21. Peleg, A.Y., Seifert, H., and, Paterson, D.L. 2008. Acinetobacter baumannii: Emergence of a successful pathogen. Clinical Microbiology Reviews, 21: 538-582.
22. Pfeifer, Y., Wilharm, G., Zander, E., Wichelhaus, T.A., Gottig, S. H., Higgins, P.G. (2011). Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. Journal of Antimicrobial Chemotherapy, 66 (9), 1998-2001.
23. Pitlik, S. 2003. Old drugs for new bugs. British Medical Journal, 326: 235-236.
24. Poirel, L., Ros, A., Carricajo, A., Berthelot, P., Pozzetto, B., Bernabeu, S.,., and, Nordmann, P. 2010. Extremely drug-resistant Citrobacter freundii identified in a patient returning from India and producing NDM-1 and other carbapenemases. Antimicrobial Agents and Chemotherapy, 55: 447-448.
25. Qi, C., Malczynski, M., Parker, M., and, Scheetz, M.H. 2008. Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007. Clinical Microbiology, 46: 1106-1109.
26. Rolain, J.M., Parola, P., and, Cornaglia, G. 2010. New Delhi metallo-b-lactamase (NDM-1): Towards a new pandemia?. Clinical Microbiology & Infection, 16: 1699-1701.
27. Schneider, K.D., Ortega, C.J., Renck, N.A., Bonomo, R.A., Powers, R.A., and, Leonard, D.A. 2011. Structures of the class D carbapenemase OXA-24 from Acinetobacter baumannii in complex with doripenem. Journal of Molecular Biology, 406 (4): 583-594.
28. Shahid, M., Sobia, F., Singh, A., Malik, A., Khan, H.M., Jonas, D., and, Hawkey, P.M. 2009. Beta-lactams and Beta-lactamase-inhibitors in current-or potential-clinical practice: A comprehensive update. Critical Reviews in Microbiology, 35 (2): 81-108.
29. Tambunan, U.S.F., Noors, R.S., Parikesit, A.A., Elyana, and, Ronggo, W. 2011. Molecular dynamics simulation of DENV RNA-dependent RNA-polymerase with potential inhibitor of disulfide cyclic peptide. Online Journal of Biological Sciences, 11 (2): 48-62.
30. Tamilselvi, A., Nethaji, M., and, Mugesh, G. 2006. Antibiotic resistance: Mono and binuclear Zinc complex as metallo β-lactamases mimics. Chemistry A European Journal, 12: 7597-7606.
31. Tiwari, V., Kapil, A., & Moganty, R.R. (2012b). Carbapenem- hydrolyzing oxacillinase in high resistant strains of Acinetobacter baumannii isolated from India. Microbial Pathogenesis, 53 (2), 81-86.
32. Tiwari,V., Nagpal, I., Subbarao N., & Moganty, R.R. (2012c). In-silico modeling of a novel OXA-51 from β-lactam-resistant Acinetobacter baumannii and its interaction with various antibiotics. Journal of Molecular Modeling, 18 (7), 3351-3361.
33. Tiwari, V., Vashistt, J., Kapil, A., & Moganty R.R. (2012a). Comparative proteomics of inner membrane fraction from carbapenem-resistant Acinetobacter baumannii with a reference strain. PLoS ONE, 7 (6), e39451.
34. Vashist, J., and, Rajeswari, M.R. 2006. Structural investigations on novel porin, OmpAb from Acinetobacter baumannii. Journal of Biomolecular Structure and Dynamics, 24: 243-253.
35. Vashist, J., Tiwari, V., Das, R., Kapil, A., and, Rajeswari, M.R. 2011. Analysis of penicillin-binding proteins (PBPs) in carbapenem resistant Acinetobacter baumannii. Indian Journal of Medical Research, 133: 332-338.
36. Vashist, J., Tiwari, V., Kapil, A., and, Rajeswari, M.R. 2010. Quantitative profiling and identification of outer membrane proteins of β-lactam resistant strain of Acinetobacter baumannii. Journal of Proteomic Research, 9: 1121-1128.
37. Vashist, J., Tiwari, V., Kapoor, R., Kapil, A., Yennamalli, R., Subbarao, N., and, Rajeswari, M.R. 2009. Interaction of nalidixic acid and ciprofloxacin with wild type and mutated quinolone-resistance-determining region of DNA gyrase A. Indian Journal of Biochemistry, 46: 147-153.
38. Vila, J., Mart, S., and, Sanchez-Cespedes, J. 2007. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy, 59: 1210-1215.
39. Walsh, T.R. 2008. Clinically significant carbapenemases: An update. Current Opinion in Infectious Diseases, 21: 367-371.
40. Walsh, T.R., Toleman, M.A., Poirel, L., and, Nordmann, P. 2005. Metallo-beta-lactamases: The quiet before the storm?. Clinical Microbiology Reviews, 18: 306-325.
41. Wommer, S., Rival, S., Heinz, U., Galleni, M., Frere, J.M., Franceschini, N., Amicosante, G., Rasmussen, B., Bauer, R., and, Adolph, H.W. 2002. Substrate activated zinc binding of metallo-beta-lactamases: Physiological importance of mononuclear enzymes. Journal of Biological Chemistry, 277: 24142-24147.
42. Yamaguchi, Y., Jin, W., Matsunaga, K., Ikemizu, S., Yamagata, Y., Wachino, J., Shibata, N., Arakawa, Y., and, Kurosaki, H. 2007. Crystallographic investigation of the inhibition mode of a VIM-2 metallo-beta-lactamase from Pseudomonas aeruginosa by a mercaptocarboxylate inhibitor. Journal of Medicinal Chemistry, 27, 50 (26): 6647-6653.
43. Yao, J.D., and, Moellering, R.C. 1991. " Antimicrobial agents ". In Manual of clinical microbiology, 5th ed., Edited by: Balows, A., Houston, W., Hermann, K.L. and Isenberg, H. 1065-1099. Washington, DC: American Society for Microbiology.
44. Yong, D., Toleman, M.A., Giske, C.G., Cho, H.S., Sundman, K., Lee, K.,., and, Walsh, T.R. 2009. Characterization of a new metallo-b-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumonia sequence type 14 from India. Antimicrobial Agents and Chemotherapy, 53: 5046-5054.